Condition

Non-obstructive Hypertrophic Cardiomyopathy clinical trials and research

• 2Clinical trials
• 12Countries

All recruiting trials (2)

• Ninerafaxstat for symptomatic non-obstructive hypertrophic cardiomyopathy

  This trial will test whether taking ninerafaxstat with usual care helps adults with symptomatic non-obstructive hypertrophic cardiomyopathy feel better and improve exercise capacity compared with a placebo.

  Recruiting at 63 sites Phase 2 Imbria Pharmaceuticals, Inc. · La Jolla, California and 75 other locations · NCT07023614

• Comparing Bisoprolol and Verapamil for treating symptoms in patients with non-obstructive hypertrophic cardiomyopathy

  This study tests whether Bisoprolol or Verapamil can help people with non-obstructive hypertrophic cardiomyopathy feel better by reducing symptoms like shortness of breath and chest pain.

  Recruiting at 2 sites Phase 4 Aarhus University Hospital Skejby · Aarhus N and 3 other locations · NCT05569382

Quick answers

How many Non-obstructive Hypertrophic Cardiomyopathy clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in Austria (1 trial), Belgium (1 trial), France (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →